Back to search
Intracerebral Hemorrhagic Stroke
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intracerebral Hemorrhagic Stroke trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Intracerebral Hemorrhagic Stroke trials you may qualify forThe objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous…
The goal of this study is to determine if Minocycline, when added to standard care, can improve survival and functional outcomes in patients with moderate acute…
The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard…
The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
This multicenter, pragmatic randomized, open-label clinical trial aims to assess whether Tranexamic Acid improves outcomes in adult patients with spontaneous in…
Stroke, especially acute ischemic stroke (AIS) caused by a blocked blood vessel in the brain, is a leading cause of death and long-term disability. When the blo…
The goal is to pilot test a highly accessible, web-based, pragmatic, scalable intervention to overcome ongoing problems with high stakes decision-making by surr…
The goal of this clinical trial is to investigate the use of DECT (Dual-Energy Computed Tomography) in patients with acute ischemic stroke who receive an interv…
The overall purpose of this study is to look at the safety and effectiveness of administering Tenecteplase (TNK) into the brain bleed (hematoma) instead of anot…